276 related articles for article (PubMed ID: 36271948)
1. Saliva metabolomic profile of COVID-19 patients associates with disease severity.
Saheb Sharif-Askari N; Soares NC; Mohamed HA; Saheb Sharif-Askari F; Alsayed HAH; Al-Hroub H; Salameh L; Osman RS; Mahboub B; Hamid Q; Semreen MH; Halwani R
Metabolomics; 2022 Oct; 18(11):81. PubMed ID: 36271948
[TBL] [Abstract][Full Text] [Related]
2. Urine metabolomics links dysregulation of the tryptophan-kynurenine pathway to inflammation and severity of COVID-19.
Dewulf JP; Martin M; Marie S; Oguz F; Belkhir L; De Greef J; Yombi JC; Wittebole X; Laterre PF; Jadoul M; Gatto L; Bommer GT; Morelle J
Sci Rep; 2022 Jun; 12(1):9959. PubMed ID: 35705608
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation.
Ceballos FC; Virseda-Berdices A; Resino S; Ryan P; Martínez-González O; Peréz-García F; Martin-Vicente M; Brochado-Kith O; Blancas R; Bartolome-Sánchez S; Vidal-Alcántara EJ; Albóniga-Díez OE; Cuadros-González J; Blanca-López N; Martínez I; Martinez-Acitores IR; Barbas C; Fernández-Rodríguez A; Jiménez-Sousa MÁ
Front Immunol; 2022; 13():925558. PubMed ID: 35844615
[TBL] [Abstract][Full Text] [Related]
4. Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome.
Roberts I; Wright Muelas M; Taylor JM; Davison AS; Xu Y; Grixti JM; Gotts N; Sorokin A; Goodacre R; Kell DB
Metabolomics; 2021 Dec; 18(1):6. PubMed ID: 34928464
[TBL] [Abstract][Full Text] [Related]
5. Amino Acid Metabolism is Significantly Altered at the Time of Admission in Hospital for Severe COVID-19 Patients: Findings from Longitudinal Targeted Metabolomics Analysis.
Ansone L; Briviba M; Silamikelis I; Terentjeva A; Perkons I; Birzniece L; Rovite V; Rozentale B; Viksna L; Kolesova O; Klavins K; Klovins J
Microbiol Spectr; 2021 Dec; 9(3):e0033821. PubMed ID: 34878333
[TBL] [Abstract][Full Text] [Related]
6. Metabolic predictors of COVID-19 mortality and severity: a survival analysis.
Abdallah AM; Doudin A; Sulaiman TO; Jamil O; Arif R; Sada FA; Yassine HM; Elrayess MA; Elzouki AN; Emara MM; Thillaiappan NB; Cyprian FS
Front Immunol; 2024; 15():1353903. PubMed ID: 38799469
[TBL] [Abstract][Full Text] [Related]
7. Untargeted detection of the carbonyl metabolome by chemical derivatization and liquid chromatography-tandem mass spectrometry in precursor ion scan mode: Elucidation of COVID-19 severity biomarkers.
Gomez-Gomez A; Rodríguez-Morató J; Haro N; Marín-Corral J; Masclans JR; Pozo OJ
Anal Chim Acta; 2022 Mar; 1196():339405. PubMed ID: 35151400
[TBL] [Abstract][Full Text] [Related]
8. Quantitative LC-MS study of compounds found predictive of COVID-19 severity and outcome.
Roberts I; Wright Muelas M; Taylor JM; Davison AS; Winder CL; Goodacre R; Kell DB
Metabolomics; 2023 Oct; 19(11):87. PubMed ID: 37853293
[TBL] [Abstract][Full Text] [Related]
9. Untargeted saliva metabolomics by liquid chromatography-Mass spectrometry reveals markers of COVID-19 severity.
Frampas CF; Longman K; Spick M; Lewis HM; Costa CDS; Stewart A; Dunn-Walters D; Greener D; Evetts G; Skene DJ; Trivedi D; Pitt A; Hollywood K; Barran P; Bailey MJ
PLoS One; 2022; 17(9):e0274967. PubMed ID: 36137157
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics study of COVID-19 patients in four different clinical stages.
Valdés A; Moreno LO; Rello SR; Orduña A; Bernardo D; Cifuentes A
Sci Rep; 2022 Jan; 12(1):1650. PubMed ID: 35102215
[TBL] [Abstract][Full Text] [Related]
11. Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection.
D'Amora P; Silva IDCG; Budib MA; Ayache R; Silva RMS; Silva FC; Appel RM; Júnior SS; Pontes HBD; Alvarenga AC; Arima EC; Martins WG; Silva NLF; Diaz RS; Salzgeber MB; Palma AM; Evans SS; Nagourney RA
PLoS One; 2021; 16(12):e0259909. PubMed ID: 34851990
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients.
Marín-Corral J; Rodríguez-Morató J; Gomez-Gomez A; Pascual-Guardia S; Muñoz-Bermúdez R; Salazar-Degracia A; Pérez-Terán P; Restrepo MI; Khymenets O; Haro N; Masclans JR; Pozo OJ
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946479
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status.
Thomas T; Stefanoni D; Reisz JA; Nemkov T; Bertolone L; Francis RO; Hudson KE; Zimring JC; Hansen KC; Hod EA; Spitalnik SL; D'Alessandro A
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32559180
[TBL] [Abstract][Full Text] [Related]
14. Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease 19.
Occelli C; Guigonis JM; Lindenthal S; Cagnard A; Graslin F; Brglez V; Seitz-Polski B; Dellamonica J; Levraut J; Pourcher T
Front Med (Lausanne); 2022; 9():995069. PubMed ID: 36250098
[TBL] [Abstract][Full Text] [Related]
15. Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction.
Lodge S; Lawler NG; Gray N; Masuda R; Nitschke P; Whiley L; Bong SH; Yeap BB; Dwivedi G; Spraul M; Schaefer H; Gil-Redondo R; Embade N; Millet O; Holmes E; Wist J; Nicholson JK
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511373
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the Kynurenine-Tryptophan Pathway and Lipid Dysregulation Are Preserved Features of COVID-19 in Hemodialysis.
Schuller M; Oberhuber M; Prietl B; Zügner E; Prugger EM; Magnes C; Kirsch AH; Schmaldienst S; Pieber T; Brodmann M; Rosenkranz AR; Eller P; Eller K
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430566
[TBL] [Abstract][Full Text] [Related]
17. Salivary metabolomics profile of patients with recurrent aphthous ulcer as revealed by liquid chromatography-tandem mass spectrometry.
Li Y; Wang D; Zeng C; Liu Y; Huang G; Mei Z
J Int Med Res; 2018 Mar; 46(3):1052-1062. PubMed ID: 29332424
[TBL] [Abstract][Full Text] [Related]
18. A combination of Q-TOF LC/MS and LC-MS/MS based metabolomics in pediatric-onset multiple sclerosis demonstrates potential biomarkers for unclassified patients.
Solmaz İ; Kaplan O; Çelebier M; Lay İ; Anlar B
Turk J Med Sci; 2022 Aug; 52(4):1299-1310. PubMed ID: 36326407
[TBL] [Abstract][Full Text] [Related]
19. Plasma metabolomics and gene regulatory networks analysis reveal the role of nonstructural SARS-CoV-2 viral proteins in metabolic dysregulation in COVID-19 patients.
Ivanisenko VA; Gaisler EV; Basov NV; Rogachev AD; Cheresiz SV; Ivanisenko TV; Demenkov PS; Mishchenko EL; Khripko OP; Khripko YI; Voevoda SM; Karpenko TN; Velichko AJ; Voevoda MI; Kolchanov NA; Pokrovsky AG
Sci Rep; 2022 Nov; 12(1):19977. PubMed ID: 36404352
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in COVID-19 Patients.
Oliveira LB; Mwangi VI; Sartim MA; Delafiori J; Sales GM; de Oliveira AN; Busanello ENB; Val FFAE; Xavier MS; Costa FT; Baía-da-Silva DC; Sampaio VS; de Lacerda MVG; Monteiro WM; Catharino RR; de Melo GC
Front Microbiol; 2022; 13():844283. PubMed ID: 35572676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
